SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ng JK, Urbanski SJ, Mangat N, et al. Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study. Cancer. 2008; 112: 362-371.
  • 2
    Rubbia-Brandt L, Giostra E, Brezault C, et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol. 2007; 18: 299-304.
  • 3
    Yamanaka N, Okamoto E, Oriyama T, et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg. 1994; 219: 342-346.
  • 4
    Levi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet. 1997; 350: 681-686.
  • 5
    Levi F. Circadian chronotherapy for human cancers. Lancet Oncol. 2001; 2: 307-15.
  • 6
    Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000; 92: 205-216.
  • 7
    Hashimoto T, Minagawa M, Aoki T, et al. Caval invasion by liver tumor is limited. J Am Coll Surg. 2008; 207: 383-392.
  • 8
    Maeba T, Okano K, Mori S, et al. Extent of pathologic invasion of the inferior vena cava in resected liver cancer compared with possible caval invasion diagnosed by preoperative images. J Hepatobiliary Pancreat Surg. 2000; 7: 299-305.
  • 9
    de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008; 248: 626-637.
  • 10
    Chun YS, Vauthey JN, Boonsirikamchai P, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009; 302: 2338-2344.
  • 11
    Abou-Alfa GK, Schwartz L, Ricci S, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006; 24: 4293-4300.
  • 12
    de Haas RJ, Wicherts DA, Flores E, et al. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008; 248: 626-637.
  • 13
    Tanaka K, Nojiri K, Kumamoto T, et al. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy. Eur J Surg Oncol. 2011; 37: 336-343.